| | |
| 1233 | Upregulation of t-PA and PAI-1 activities in oral submucous fibrosis
S.-F. YANG, Y.-S. HSIEH, C.-H. TSAI, and Y.-C. CHANG, Chung Shan Medical University, Taichung, Taiwan |
| 1234 | Nitrosation of Tyrosine in the Hamster Cheek Pouch
E.W.N. LAM1, R.D.C. BARLEY1, M.C. SHALLOW2, and E. PETERS1, 1University of Alberta, Edmonton, Canada, 2Dalhousie University, Halifax, Canada |
| 1235 | Effect of smokeless tobacco on protein nitrosation in oral keratinocytes
R.D.C. BARLEY, University of Alberta, Edmonton, Canada, and E.W.N. LAM, University of Alberta, Edmonton, Canada |
| 1236 | Sequential MMP-2 Alteration in DMBA-induced Hamster Cheek Pouch Carcinogenesis
Y.-J. CHEN, C.-H. TSAI, M.-Y. CHOU, and Y.-C. CHANG, Chung Shan Medical University, Taichung, Taiwan |
| 1237 | Microvessel Volume in Normal and Dysplastic Oral Epithelium
V.P.A. OO, University of Malaya, Kuala Lumpur, Malaysia, and C.H. SIAR, University of Malaya, Kuala Lumpur, Malaysia |
| 1238 | Bootstrap validation of ROC-based AgNOR cut-off to diagnose epithelial dysplasia
A. CHATTOPADHYAY, Temple University, Philadelphia, PA, USA, A. DASKALAKI, Free University of Berlin, Germany, D.J. CAPLAN, University of North Carolina, Chapel Hill, USA, and J.G. RAY, Dr R Ahmed Dental College & Hospital, Kolkata, India |
| 1239 | 120kDa Fibronectin Fragment : Novel Marker of Aggressive OSCC?
N. AL-HAZMI, G.J. THOMAS, P.M. SPEIGHT, and S.A. WHAWELL, Eastman Dental Institute for Oral Health Care Sciences, London, United Kingdom |
| 1240 | Extraction of RNA from oral brush biopsies in oral leukoplakia
K. PATEL, N.L. RHODUS, P. GAFFNEY, and F. ONDREY, University of Minnesota, Minneapolis, USA |
| 1241 | Innovative Diagnostic Tools for Early Oral Cancer and PMEL Detection
R. SARAVANAN, University of Malaya, Kuala Lumpur, Malaysia, and C.H. SIAR, University of Malaya, Kuala Lumpur, Malaysia |
| 1242 | Detection of High-risk Oral Premalignant Lesions by Multi-Spectral Fluorescent Visualization
L. ZHANG1, S.P. NG1, M. WILLIAMS2, D. LARONDE1, C.F. POH1, C. MACAULAY2, and M.P. ROSIN3, 1University of British Columbia, Vancouver, Canada, 2British Columbia Cancer Agency, Vancouver, Canada, 3British Columbia Cancer Agency, Simon Fraser University, Vancouver, Canada |
| 1243 | Matrix Metalloproteinase Expression in Oral Verrucous and Squamous Cell Carcinoma
V.-J. UITTO1, U. IMPOLA2, J. HIETANEN1, and U. SAARIALHO-KERE3, 1University of Helsinki, (University of British Columbia), Finland, 2University of Helsinki, 3University of Helsinki, Karolinska Institutet |
| 1244 | Patterns of MMP Expression in Oral Cancer Progression
L.A. NEIDART, M.K. DABBOUS, M. EL-TORKY, and L. HANEY, University of Tennessee, Health Science Center, Memphis, USA |
| 1245 | Long-term treatment outcome of oral premalignant lesions
P. HOLMSTRUP1, P. VEDTOFTE2, J. REIBEL1, and K. STOLTZE3, 1University of Copenhagen, Copenhagen N, Denmark, 2Copenhagen University Hospital, Denmark, 3University of Copenhagen, Denmark |
| 1246 | TP53 mutations and progression of premalignant oral lesions
H.M. ÖGMUNDSDÓTTIR1, J. BJÖRNSSON2, and W.P. HOLBROOK2, 1Icelandic Cancer Society, University of Iceland, Reykjavík, Iceland, 2University of Iceland, Reykjavik, Iceland |
| 1247 | Apoptotic cells in brush biopsies of patients with oral leukoplakia
J. HAWS1, N.L. RHODUS2, B. WILLIAMS2, and R. GRIFFIN2, 1University of Minnesota, Division of Oral Medicine, Minneapolis, USA, 2University of Minnesota, Minneapolis, USA |
|